Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer

Background. This open-label, single-arm, two-stage, Phase II study investigated the efficacy and safety of bi-weekly pemetrexed combined with irinotecan, in patients with metastatic colorectal cancer (mCRC), after first-line chemotherapy using FOLFOX regimen. Patients and methods. Patients received...

Descripción completa

Detalles Bibliográficos
Autores principales: Louvet, C., André, T., Gamelin, E., Hebbar, M., Mabro, M., Bennamoun, M., Rassam, H., de Gramont, A.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852604/
https://www.ncbi.nlm.nih.gov/pubmed/20396391
http://dx.doi.org/10.1155/2010/785934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852604/
https://www.ncbi.nlm.nih.gov/pubmed/20396391
http://dx.doi.org/10.1155/2010/785934

Ejemplares similares